(Press-News.org) A major clinical trial, led by experts at the University of Nottingham, has shown the Lee Silverman Voice Treatment (LSVT LOUD®) is more effective than the current speech and language therapy provided by the NHS, when treating patients with Parkinson’s disease (PD).
The results of the NIHR HTA funded trial, which are published today in the BMJ, showed that LSVT LOUD® was more effective at reducing the participant’s reported impact of voice problems than no speech and language therapy, as well as the NHS delivered speech and language therapy.
The trial was led by experts from the Universities of Nottingham and Birmingham, along with colleagues at Sandwell and Dudley Hospital Trust, University College London, King’s College London, the University of Bangor, Canterbury Christ Church University and Glasgow Caledonian University.
It was carried out by NHS Speech and Language Therapy services across the UK and co-ordinated and analysed by the team at the Birmingham Clinical Trials Unit (BCTU) at the University of Birmingham.
Professor Catherine Sackley, from the School of Health Sciences and the NIHR Nottingham Biomedical Research Centre, led the study. She says: “The impact of speech and communication problems in people with PD can cause them to feel stigmatised. It can stop them going out, stop them socialising, and stop them doing day-to-day tasks such as shopping, which can have a detrimental impact on their quality of life.
“This is the first study of its kind to look at the most effective treatment options. The results clearly show that, delivered in this way, the LSVT LOUD® method is both effective and it can be cost effective. The NHS method as it is currently delivered is not effective. Now we have this data, we need to look at other factors and whether if different therapies are delivered in different ways, this would further impact the results.”
Building on a pilot study funded by The Dunhill Medical Trust, participants were recruited from 40 NHS sites across the UK and were randomised into three groups. One group received the LSVT LOUD®, one received the current NHS speech and language treatment and the third didn’t receive any therapy.
LSVT LOUD® is an effective speech treatment for people with PD and other neurological conditions. The treatment trains people with PD to use their voice at a more normal loudness level while speaking at home, work, or in the community. Patients are given voice exercises to do this.
The NHS treatment is a personalised programme delivered by a therapist and is less intensive. It is delivered over six to eight sessions rather than the LSVT LOUD® which is delivered in 16 sessions over four weeks.
Between September 2016 and March 2020, 388 people with PD and Dysarthria (difficulty speaking) took part in the trial. 130 were allocated to the LSVT LOUD® group, 129 to the NHS therapy group and 129 received none.
LSVT LOUD® consisted of four face-to-face or remote 50-minute sessions, each week delivered over four weeks, with additional home-based practice. The NHS speech and language therapy was determined by the local therapist in response to a participant’s individual needs, an average of one session every other week was delivered over 11 weeks.
The findings of the trial showed that LSVT LOUD® was more effective at reducing the impact of Dysarthria than no speech and language therapy and the NHS version. The NHS therapy showed no evidence of benefit compared to no speech and language therapy.
Adrian Wrigley, who has Parkinson's said: “Speech and language therapy research is very important to me personally, as I've seen firsthand how the loss or reduction of our main communication tool leads to higher levels of frustration and anxiety not only for those of us with Parkinson's but our partners and friends. So the development of a treatment that works is very important for the Parkinson's community.”
The study was funded by the National Institute for Health Research, Health Technology Assessment programme.
END
Major trial looks at most effective speech therapy for people with Parkinson’s disease
2024-07-11
ELSE PRESS RELEASES FROM THIS DATE:
Intensive voice treatment more effective than NHS speech therapy for Parkinson’s disease
2024-07-11
An intensive voice treatment developed in the USA and known as the Lee Silverman voice treatment (LSVT LOUD) is more effective than conventional NHS speech and language therapy or no therapy for people with Parkinson’s disease, finds a trial published in The BMJ today.
The researchers say the results emphasise the need to optimise the use of speech and language therapy resources for people with Parkinson’s disease.
Slurred or slow speech (known as dysarthria) is a common feature of Parkinson’s disease and can have a significant effect ...
NHS’s relentless focus on finance and productivity is failing patient safety
2024-07-11
“The NHS’s relentless focus on finance and productivity is failing patient safety,” argues patient safety commissioner Henrietta Hughes in an interview for The BMJ today.
“The patient’s anecdote is the canary in the coal mine,” she says. It’s the thing that tells us there’s something going wrong. But too often we hear about patients who have raised concerns being gaslighted, dismissed, and fobbed off.”
Hughes, a GP and former medical director at NHS England, became England’s first independent patient safety commissioner in September 2022.
The job was created ...
World leaders unite to embed social participation in health systems
2024-07-11
For the first time in the World Health Organization’s 76 year history, world leaders have unanimously committed to put social participation - people, communities and civil society - at the heart of health decision making processes.
This landmark pledge marks an important step forward in creating a healthy world, say experts in The BMJ today, and they urge everyone to seize their right to influence the decisions that affect their health and well-being.
Global challenges such as access to care, climate change, widening ...
AI Chatbots have shown they have an ‘empathy gap’ that children are likely to miss
2024-07-11
Artificial intelligence (AI) chatbots have frequently shown signs of an “empathy gap” that puts young users at risk of distress or harm, raising the urgent need for “child-safe AI”, according to a study.
The research, by a University of Cambridge academic, Dr Nomisha Kurian, urges developers and policy actors to prioritise approaches to AI design that take greater account of children’s needs. It provides evidence that children are particularly susceptible to treating chatbots as lifelike, quasi-human confidantes, ...
Dante on the Move: Refugee’s share experiences through the lens of 14th century poet
2024-07-11
International refugees and academic experts have contributed to a new book examining the resonance of Dante’s Divine Comedy with today’s migrants fleeing the troubles in their home countries.
Dante on the Move is launched in Rome today (Thursday 11th July) and has been produced as part of a research project Reading Dante with Refugees led by the University of Birmingham and Trinity College Rome. It features work by people from Afghanistan, China, Egypt, Iran, Iraq, Kurdistan, Ukraine, the USA and Venezuela.
Mohammed, a Kurdish refugee from Iraqi and contributor to the book survived a shipwreck in the Mediterranean in which many people drowned. He said: “Reading ...
Loneliness increases risk of age-related memory loss
2024-07-10
About a third of Canadians feel lonely, and a study from the University of Waterloo shows it has a greater negative impact on memory than even social isolation, though both present a significant risk to the aging population.
Loneliness is a subjective emotion that people might feel even while engaging in social activities. It is often associated with depression and an increase in stress hormones that may contribute to impaired memory.
Waterloo researchers examined four combinations of social isolation ...
Study: Nanoparticle vaccines enhance cross-protection against influenza viruses
2024-07-10
ATLANTA — To offer cross-protection against diverse influenza virus variants, nanoparticle vaccines can produce pivotal cellular and mucosal immune responses that enhance vaccine efficacy and broaden protection, according to a study by researchers in the Institute for Biomedical Sciences at Georgia State University.
The study, published in the journal Nature Communications, offers valuable insights into tailoring immunization strategies to optimize influenza vaccine effectiveness. To alleviate the significant ...
Student leadership development requires holistic approach, educators say
2024-07-10
URBANA, Ill. – Colleges and universities often highlight leadership development as a critical component of their curriculum — but there is no clear consensus on what constitutes effective leadership education. In a new paper, two educators from the University of Illinois Urbana-Champaign and John Carroll University provide a roadmap for training competent leaders, suggesting a comprehensive, practical approach for postsecondary institutions to follow.
“Our purpose was to discuss what it means to develop leaders and what a model for leadership education could ...
Mars likely had cold and icy past, new study finds
2024-07-10
The question of whether Mars ever supported life has captivated the imagination of scientists and the public for decades. Central to the discovery is gaining insight into the past climate of Earth’s neighbor: was the planet warm and wet, with seas and rivers much like those found on our own planet? Or was it frigid and icy, and therefore potentially less prone to supporting life as we know it? A new study finds evidence to support the latter by identifying similarities between soils found on Mars and those of Canada’s Newfoundland, a cold subarctic climate.
The study, published July 7th in Communications Earth and Environment, looked for soils on Earth with ...
Taylor Swift’s impact on fans’ body image attitudes mostly positive, research shows
2024-07-10
Taylor Swift’s past struggles with body image, disordered eating, and body objectification have had an overall positive influence on her fans’ attitudes on these issues, a new study from University of Vermont (UVM) researchers finds.
The new research, published in journal Social Science & Medicine, analyzed the top 200 TikTok and Reddit posts—including over 8,300 online comments—about Taylor Swift, eating disorders, and body image to determine the impact of Swift’s disclosures about her past eating disorder on her fans.
“Our findings suggest that fans who felt highly connected to Swift were influenced to positively change their behaviors ...